OptionsHouse

Options Trading News

July 2, 2013  Tue 9:38 AM CT

ACT: SEE CHART GET CHAIN FIND STRATEGIES
A trader is looking for a floor in shares of pharmaceutical company Actavis ahead of its earnings report later this month.

optionMONSTER's tracking systems detected the sale of 3,100 August 110 puts in one print for $1 this morning. This is clearly a new position, as open interest in the strike was just 263 contracts before the trade appeared.

The put seller will keep the $1 credit as profit if ACT is above $110 at expiration in mid-August. If the stock is below that strike price, the trader will be on the hook to buy shares at that level. (See our Education section)

ACT is up fractionally this morning at $125.67. The stock spiked up from below $107 on May 10, the day of its annual shareholder meeting, and has been trading in an increasingly tight range since. The drug developer is scheduled to report second-quarter results on July 25.

Today's put sale has dominated the total option volume in the name so far today, which is already more than triple its daily average for the last month.
Share this article with your friends


Related Stories

ACT

How trader draws income in Actavis

April 24, 2015

The drug maker is up 16 percent so far this year, having grown by acquiring other companies including Allergan, Warner Chilcott, and Durata Therapeutics.

Invest Like a Monster - San Diego: June 26-27

Premium Services

Education & Strategy

Introduction to Synthetics

"Synthetics" is the name given to the relationship of two separate positions, constructed differently, that have the same exact risk and reward at each and every price level. They say that there is more than one way to skin a cat...well, there is always more than one way to create an option position...

View more education articles »